LYTLE PAUL J has filed 4 insider transactions across 1 company since August 2024.
Most recent transaction: a grant/award of 105000 shares of ACTUATE THERAPEUTICS, INC. ($ACTU) on April 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | ACTUATE THERAPEUTICS, INC. | $ACTU | LYTLE PAUL J | Chief Financial Officer | A | Employee Stock Option (right to buy) | 105000 | $0.00 | 105,000.0000 | 23,243,328 | 9999.99% | 0.45% |
| April 1, 2025 | ACTUATE THERAPEUTICS, INC. | $ACTU | LYTLE PAUL J | Chief Financial Officer | A | Employee Stock Option (right to buy) | 49394 | $0.00 | 49,394.0000 | 19,531,636 | 9999.99% | 0.25% |
| April 1, 2025 | ACTUATE THERAPEUTICS, INC. | $ACTU | LYTLE PAUL J | Chief Financial Officer | A | Employee Stock Option (right to buy) | 41899 | $0.00 | 41,899.0000 | 19,531,636 | 9999.99% | 0.21% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | LYTLE PAUL J | Chief Financial Officer | A | Non-Qualified Stock Options | 234971 | $0.00 | 0.0000 | 0 | 0.00% | 0.00% |